（编辑 姚尧） 证券日报网讯 1月9日，雷迪克在互动平台回答投资者提问时表示，灵巧手是一种模拟人手结构与功能 的高性能末端执行器，具备高度灵活性与精准控制能力，能够复现人手的复杂动作，执行各类精细任 务，是人形机器人实现精细操作的核心部件，在商业、工业、生活等领域均具有广泛的应用场景。公司 于2025年11月战略投资上海傲意信息科技有限公司20.41%的股权。傲意科技成立于2015年，是国内少 有的同时掌握"脑机接口"+"机器人"两大技术的企业，主要产品覆盖智能仿生手、智能脑电图系统、可 穿戴外骨骼设备、机器人灵巧手等。在机器人灵巧手领域，傲意科技已与多家机器人主机客户构建了良 好的合作关系。 ...

在机器人灵巧手方面，其灵巧手已经成为国内人形机器人领域的"第一梯队"产品，合作企业超过200 家。 目前，傲意科技主要生产和销售的产品包括智能仿生手、智能脑电图系统、可穿戴外骨骼设备、机器人 灵巧手等。其中，傲意科技的智能仿生手是中国首款、全球第三款通过FDA和CE认证的高端义肢，销 售覆盖美国、中东、俄罗斯、乌克兰、印度等全球多个国家和地区。 格隆汇1月5日丨雷迪克(300652.SZ)近日在线上交流活动中表示，傲意科技成立于2015年，是国内少有 的同时掌握"脑机接口"+"机器人"两大技术的企业，通过神经接口、机器人核心零部件等底层技术，多 年专注于神经康复医疗、智能辅具、大健康消费电子、机器人零部件和控制系统等业务板块。 ...

在机器人灵巧手方面，其灵巧手已经成为国内人形机器人领域的"第一梯队"产品，合作企业超过200 家。 格隆汇1月5日丨雷迪克(300652.SZ)近日在线上交流活动中表示，傲意科技成立于2015年，是国内少有 的同时掌握"脑机接口"+"机器人"两大技术的企业，通过神经接口、机器人核心零部件等底层技术，多 年专注于神经康复医疗、智能辅具、大健康消费电子、机器人零部件和控制系统等业务板块。目前，傲 意科技主要生产和销售的产品包括智能仿生手、智能脑电图系统、可穿戴外骨骼设备、机器人灵巧手 等。其中，傲意科技的智能仿生手是中国首款、全球第三款通过FDA和CE认证的高端义肢，销售覆盖 美国、中东、俄罗斯、乌克兰、印度等全球多个国家和地区。 ...

证券代码：300652 证券简称：雷迪克 当然，从技术准备到广泛落地仍面临一系列挑战，主要包括： 信号采集精度与安全性的平衡、神经解码的准确性与实时性、双 向交互技术的成熟度，以及底层神经科学认知和工程化集成的瓶 颈。这些问题的突破，需要政策引导下的跨学科长期攻关。 相较于神经科学研究的长期性，工程问题的解决进展可能相 对较快。当前面临的工程挑战主要包括高密度、低功耗的植入式 芯片设计、高通量神经数据的无线传输，以及高算力、低延迟的 实时解码系统构建等，所涉及到的材料科学、集成电路、通信技 术的发展，极大程度的带动了工程化技术的应用突破。 4、傲意科技在脑机接口领域有哪些核心技术与应用？ 在脑机接口领域，傲意科技目前主要采用的是非侵入式技术 和工程实现道路，主要的研发投入包括高精度脑电图机、肌电图 机软硬件和算法系统的研制等，目前落地应用主要有三类： 杭州雷迪克节能科技股份有限公司 投资者关系活动记录表 编号：2026-001 | 特定对象调研 | 分析师会议 ☐ ☐ | | --- | --- | | 媒体采访 | ☐ ☐ 业绩说明会 | | 投资者关系活动类别 ☐ 新闻发布会 | ☐ 路演活动 | | ☐ ...

Core Viewpoint - The strategic cooperation agreement between Hangzhou Redik Energy Technology Co., Ltd. and Shanghai Aoyi Information Technology Co., Ltd. aims to establish a joint venture focused on the research and application of robotic dexterous hands and related components [1][2]. Group 1: Joint Venture Details - The joint venture, Zhejiang Lei Ao Robotics Co., Ltd., will have a registered capital of 100 million yuan, with Redik contributing 90 million yuan (90%) and Aoyi contributing 10 million yuan (10%) [1]. - After the completion of this transaction, the joint venture will become a subsidiary of Redik and will be included in the company's consolidated financial statements [1]. Group 2: Company Backgrounds - Aoyi Technology specializes in the research and development of neural interfaces and robotics technology, producing products such as intelligent bionic hands and wearable exoskeleton devices, primarily targeting the medical rehabilitation and robotics sectors [1]. - Redik's main business involves the research, production, and sales of automotive bearings, with a strong foundation in the automotive parts manufacturing industry [1]. Group 3: Strategic Collaboration - The collaboration will leverage Redik's expertise in automotive parts manufacturing and quality control, alongside Aoyi's capabilities in electronic control and robotic components, to enhance technology development, market expansion, and supply chain integration [2]. - The partnership aims to provide comprehensive solutions from dexterous hands to robotic systems, thereby increasing customer loyalty and the value of individual components [2].

Group 1 - Reddick plans to acquire a 20.41% stake in Aoyi Technology for approximately 160 million yuan, enhancing its position in the robotics industry [2][3] - Aoyi Technology, established in 2015, specializes in brain-machine interfaces and robotics, producing products like smart bionic hands and wearable exoskeletons, with a strong market presence in education, rehabilitation, and humanoid robotics [2] - The strategic investment aims to strengthen Reddick's vertical integration capabilities from core robotic components to complete systems, further solidifying its market leadership [3] Group 2 - In the past 10 days, 747 companies were surveyed by institutions, with 293 receiving attention from overseas institutions, highlighting significant interest in the market [5] - Huaming Equipment was the most researched company, with 71 overseas institutions participating, reporting a 45.4% increase in overseas revenue for the first three quarters [5] - 16 companies that received overseas institutional research saw their net profits double, with notable performers including Lixun Precision, which reported a 24.69% increase in revenue to 220.915 billion yuan [8][9]

Group 1 - Reddick plans to acquire a 20.41% stake in Aoyi Technology for approximately 160 million yuan, enhancing its position in the robotics industry [2][3] - Aoyi Technology, established in 2015, specializes in brain-machine interfaces and robotics, producing products like intelligent bionic hands and wearable exoskeletons, with a strong market presence in education, neuroscience rehabilitation, and humanoid robotics [2] - Aoyi Technology has established partnerships with several well-known domestic companies and has received FDA and FCC certifications, allowing it to sell products in multiple countries including the USA, Middle East, and India [2] Group 2 - Reddick's strategic investment in Aoyi Technology is a key move to strengthen its vertical integration capabilities in the robotics sector, aiming to enhance its market leadership [3] - Reddick has been actively expanding its robotics industry footprint through a combination of self-research and acquisitions, including the establishment of a wholly-owned subsidiary focused on embodied intelligence [3] Group 3 - In the past 10 days, 747 companies have been surveyed by institutions, with securities companies conducting the most surveys [5] - 11 companies received significant attention from overseas institutions, with Huaming Equipment being the most researched, attracting 71 overseas institutions [6] - Lixun Precision reported a revenue of 220.915 billion yuan in the first three quarters, with a year-on-year growth of 24.69%, indicating strong performance in the data center business [8]

Core Viewpoint - The company Radik has completed a strategic investment in Shanghai Aoyi Technology Co., Ltd., acquiring a 20.41% stake through a cash transaction totaling approximately 159.99 million RMB, which includes both equity transfer and capital increase [1][3] Group 1: Investment Details - Radik's board approved the acquisition of 13.33% equity in Aoyi Technology, along with an additional capital increase to hold a total of 20.41% equity post-transaction [1] - The total consideration for the equity transfer and capital increase amounts to approximately 159.99 million RMB [1] Group 2: Company Overview - Aoyi Technology specializes in brain-machine interfaces and robotics, focusing on the development, production, and sales of human-machine interaction technologies and core robotic components [2] - The company has established partnerships with several well-known domestic enterprises in education, neuroscience rehabilitation, and humanoid robotics, accumulating a rich customer base [2] - Aoyi Technology's products have received FDA and FCC certifications, with sales extending to multiple countries including the USA, Middle East, Russia, Ukraine, and India [2] Group 3: Strategic Importance - The investment in Aoyi Technology is a key move for Radik to deepen its layout in the robotics industry, enhancing vertical integration capabilities from core components to system assemblies [3] - By producing high-precision core components, the company aims to control costs and ensure supply chain security, establishing technical and cost barriers [3] - Leveraging Aoyi Technology's advantages, Radik seeks to strengthen its design and manufacturing capabilities in linear actuator modules, creating a comprehensive technical system and manufacturing capability [3]

Core Viewpoint - The company Redick plans to acquire a 20.41% stake in Aoyi Technology for approximately 160 million yuan through cash transactions, indicating a strategic investment in the high-tech sector focused on brain-machine interfaces and robotics [1] Company Summary - Redick will purchase 744,100 yuan of registered capital from Aoyi Technology and will also increase its capital contribution to the company [1] - Aoyi Technology specializes in two core technologies: brain-machine interfaces and robotics, focusing on the research and development of human-machine interaction technologies [1] - The main products of Aoyi Technology include intelligent bionic hands, dexterous hands, smart EEG machines, and wearable exoskeleton devices, which are widely used in education, research, neurological rehabilitation, and humanoid robotics [1] Industry Summary - Aoyi Technology targets both medical and industrial applications with its bionic and dexterous hand products, leveraging its first-mover advantage in the fields of neural interfaces and robotics [1] - The company has established core competitiveness in product performance and cost control, positioning itself among the leaders in the domestic hand-shaped robotics industry [1]

Core Insights - The company Radik has approved a strategic investment in Shanghai Aoyi Technology Co., Ltd, acquiring 13.33% equity and increasing its capital investment to enhance its position in the robotics industry [1] - Aoyi Technology specializes in brain-machine interfaces and robotics, focusing on the development, production, and sales of human-machine interaction technologies and robotic components [2] - This investment aims to strengthen the company's vertical integration capabilities in the robotics sector, enhancing its competitive edge by controlling costs and securing the supply chain [3] Company Overview - Aoyi Technology is a high-tech enterprise with core technologies in brain-machine interfaces and robotics, producing products like intelligent bionic hands and wearable exoskeletons [2] - The company has established partnerships with several well-known domestic enterprises in education, neuroscience rehabilitation, and humanoid robotics, accumulating a rich customer base [2] - Aoyi Technology has received FDA and FCC certifications, with its products sold in multiple countries including the USA, Middle East, Russia, Ukraine, and India [2] Strategic Implications - The investment in Aoyi Technology is a key move for the company to deepen its layout in the robotics industry, aiming to enhance its vertical integration from core components to system assembly [3] - By producing high-precision core components in-house, the company aims to control costs while ensuring supply chain security, creating technical and cost barriers [3] - The collaboration with Aoyi Technology will further strengthen the company's capabilities in the design, assembly, and mass manufacturing of linear actuator modules, establishing a comprehensive technical system and manufacturing capability [3]